Bajaj Healthcare grants 275 ESOPs at ₹5 per option
Bajaj Healthcare's Nomination & Remuneration Committee approved the grant of 275 stock options to an eligible employee under its 2024 plan. The options, priced at ₹5 each, are convertible into one fully paid-up equity share with a face value of ₹5. The scheme complies with SEBI (SBEB) Regulations, 2021.

*this image is generated using AI for illustrative purposes only.
Bajaj Healthcare Limited granted 275 stock options to an eligible employee under its Bajaj Healthcare Limited Employee Stock Option Plan 2024. The Nomination & Remuneration Committee approved the grant at an exercise price of ₹5 per option on July 20, 2026. Each option is convertible into one fully paid-up equity share with a face value of ₹5, covering a total of 275 equity shares.
The scheme is in terms of the SEBI (SBEB) Regulations, 2021. Options vest over a maximum period of four years from the date of grant, with a minimum period of one year between the grant and vesting. Vested options may be exercised by the grantee within five years from the date of vesting.
Grant Details
| Particulars | Details |
|---|---|
| Options Granted | 275 |
| Exercise Price | ₹5 per option |
| Face Value | ₹5 per share |
| Vesting Period | Maximum 4 years |
| Exercise Period | 5 years from vesting |
Eligibility for participation includes employees working in India or abroad, and directors who are not promoters or independent directors. The scheme excludes employees who are promoters or belong to the promoter group, as well as independent directors. Shares arising from the exercise of options are not subject to a lock-in period, though trading restrictions under the company's insider trading code apply.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Bajaj HealthCare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.75% | +5.90% | -4.27% | -2.77% | -32.44% | -7.30% |
How will the company fund potential future ESOP grants if the current pilot is successful?
What impact will the vesting schedule have on employee retention rates over the next four years?
Could the exercise price of ₹5 signal management's confidence in the company's future stock performance?


































